4th International Symposium on Hormonal Carcinogenesis

第四届激素致癌作用国际研讨会

• 批准号: 6672495
• 负责人: Jonathan J. Li
• 金额: $ 2.1万
• 依托单位: UNIVERSITY OF KANSAS MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2003
• 资助国家: 美国
• 起止时间: 2003-06-01 至 2004-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6672495
• 关键词: carcinogenesis; growth factor; hormone related neoplasm /cancer; hormones; meeting /conference /symposium; travel

DESCRIPTION (provided by applicant): The International Symposia on Hormonal Carcinogenesis (ISHC) is the premier international forum for both USA and foreign investigators dedicated to study the role of hormones and other growth regulators in the causation, promotion, and progression of hormone-associated cancers. Some of these neoplasms, specifically, breast, prostate, ovarian, and endometrial, represent the most prevalent cancers occurring in females and males in the USA and developed countries, and continue to be a major public health concern. These Symposia uniquely attract committed epidemiologists, basic scientists, and clinicians of diverse disciplines, such as cell and molecular biology, endocrinology, pharmacology, reproductive toxicology, pathology, gynecologic and urologic oncology, and epidemiology. Invited speakers are engaged in the cutting edge of hormone-related cancer and other areas of research, such as cell cycle, chromosome structure and function, epithelial-stroma interactions, genomics, and proteomics, which may have a direct bearing in leading to new developments in the field. The ISHC will be held in association with the University of Valencia Cancer Center in Valencia, Spain, June 21-25, 2003. Unique to this particular Symposium will be the integration of various disciplines within each session which bear on a single focused topic. This approach will foster a translational spirit. The seven sessions of this symposia include: 1. Breast Cancer I, Progesterone Action; 2. Breast Cancer II - Mechanisms of Genomic Instability; 3. Early In-Situ Lesions: Breast and Prostate Cancer; 4. Promotion and Prevention of Hormonal Cancers; 5. Prostate I - Androgen/Estrogen Action: 6. Prostate II - Androgen Receptor: Dependence and Resistance; and 7. Endometrium/Ovarian/ Colon Cancers. The program will also include a Plenary Symposium speaker, three State of the Art speakers, and two Poster Sessions (Epidemiology/Clinical and Molecular Biology/Metabolism). Junior investigators will be encouraged to participate in the Poster Sessions. Since these Symposia address the most recent advances in the field of hormonal carcinogenesis and hormone-dependent cancers, the proceedings will be published in book form for world-wide dissemination, as it has been in the past.

描述（由申请人提供）：国际激素致癌研讨会 (ISHC) 是美国和外国研究人员的首要国际论坛，致力于研究激素和其他生长调节剂在激素相关癌症的因果关系、促进和进展中的作用。癌症。 其中一些肿瘤，特别是乳腺癌、前列腺癌、卵巢癌和子宫内膜癌，是美国和发达国家女性和男性中最常见的癌症，并且仍然是主要的公共卫生问题。 这些研讨会以独特的方式吸引了不同学科（例如细胞和分子生物学、内分泌学、药理学、生殖毒理学、病理学、妇科和泌尿肿瘤学以及流行病学）的流行病学家、基础科学家和临床医生。 受邀演讲者从事激素相关癌症和其他研究领域的前沿研究，如细胞周期、染色体结构和功能、上皮间质相互作用、基因组学和蛋白质组学，这些领域可能对新发展产生直接影响在外地。 ISHC 将于 2003 年 6 月 21 日至 25 日在西班牙巴伦西亚与巴伦西亚大学癌症中心联合举办。本次研讨会的独特之处在于，每场会议将结合不同学科，讨论一个单一的重点主题。 这种方法将培养转化精神。 本次研讨会共七个分会场，包括： 1. 乳腺癌I，黄体酮行动； 2. 乳腺癌II——基因组不稳定的机制； 3. 早期原位病变：乳腺癌和前列腺癌； 4. 促进和预防荷尔蒙癌症； 5. 前列腺 I - 雄激素/雌激素作用： 6. 前列腺 II - 雄激素受体：依赖性和抵抗； 7. 子宫内膜癌/卵巢癌/结肠癌。 该计划还将包括一名全体研讨会发言人、三名最先进的发言人和两次海报会议（流行病学/临床和分子生物学/代谢）。 我们将鼓励初级研究者参加海报会议。 由于这些研讨会讨论了激素致癌和激素依赖性癌症领域的最新进展，因此会议记录将以书籍形式出版，以便在全世界范围内传播，就像过去一样。